non-small cell lung cancer

FDA, EMA delay review of Opdivo/Yervoy for first-line NSCLC
FDA, EMA delay review of Opdivo/Yervoy for first-line NSCLC
BioCentury
Bristol-Myers Squibb
Opdivo
FDA
EMA
Yervoy
non-small cell lung cancer
Flag link:
Daiichi Sankyo launches phase 1 trial of DS-1205 in EGFR-mutated NSCLC
Daiichi Sankyo launches phase 1 trial of DS-1205 in EGFR-mutated NSCLC
Pharmaceutical Business Review
Daiichi Sankyo
non-small cell lung cancer
DS-1205
Flag link:
TP Therapeutics Secures $80 Million Mezzanine Financing
TP Therapeutics Secures $80 Million Mezzanine Financing
CP Wire
TP Therapeutics
non-small cell lung cancer
repotrectinib
Flag link:
Merrimack Pharma’s stock plunges (again) on its latest cancer drug trial flop
Merrimack Pharma’s stock plunges (again) on its latest cancer drug trial flop
Endpoints
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
Flag link:
TP Therapeutics Secures $80 Million Mezzanine Financing
TP Therapeutics
non-small cell lung cancer
repotrectinib
Flag link:
Takeda's Alunbrig Showed Superior Intracranial Results Compared to Xalkori in Ph III Trial in Non-Small Cell Lung Cancer
Takeda's Alunbrig Showed Superior Intracranial Results Compared to Xalkori in Ph III Trial in Non-Small Cell Lung Cancer
CP Wire
Takeda
Alunbrig
Xalkori
non-small cell lung cancer
Flag link:
Takeda's Alunbrig Showed Superior Intracranial Results Compared to Xalkori in Ph III Trial in Non-Small Cell Lung Cancer
Takeda
Alunbrig
Xalkori
non-small cell lung cancer
Flag link:
Pfizer nabs fast OK for a new frontline lung cancer drug as pharma giant shows off its new R&D strategy
Pfizer nabs fast OK for a new frontline lung cancer drug as pharma giant shows off its new R&D strategy
Endpoints
R&D
Pfizer
Ian Read
dacomitinib
FDA
non-small cell lung cancer
Flag link:
Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer
Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer
CP Wire
AstraZeneca
MedImmune
Imfinzi
non-small cell lung cancer
Flag link:
Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer
AstraZeneca
Imfinzi
non-small cell lung cancer
Flag link:
Takeda Presents Superior Results for Alunbrig in ALK+ Non-Small Cell Lung Cancer
Takeda Presents Superior Results for Alunbrig in ALK+ Non-Small Cell Lung Cancer
CP Wire
Takeda
Alunbrig
non-small cell lung cancer
Flag link:
Takeda Presents Superior Results for Alunbrig in ALK+ Non-Small Cell Lung Cancer
Takeda
Alunbrig
non-small cell lung cancer
Flag link:
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Xconomy
Roche
entrectinib
Ignyta
FDA
non-small cell lung cancer
Flag link:
How Tesaro Hopes to Tackle Lung Cancer
How Tesaro Hopes to Tackle Lung Cancer
Motley Fool
Tesaro
TSR-042
non-small cell lung cancer
Flag link:
AstraZeneca gets further approval for Tagrisso in Japan
AstraZeneca gets further approval for Tagrisso in Japan
Pharmaforum
AstraZeneca
Japan
Tagrisso
non-small cell lung cancer
Flag link:
Immunicum AB Announces FDA Approval to Expand Ph Ib/II trial of Cancer Drug
Immunicum AB Announces FDA Approval to Expand Ph Ib/II trial of Cancer Drug
CP Wire
Immunicum
clinical trials
ilixadencel
head and neck cancer
non-small cell lung cancer
gastric cancer
Flag link:
Is Roche's latest Tecentriq win really a win for Merck's Keytruda?
Is Roche's latest Tecentriq win really a win for Merck's Keytruda?
Fierce Pharma
Roche
immuno-oncology
Tecentriw
Merck
Keytruda
non-small cell lung cancer
Flag link:
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
CP Wire
Seattle Genetics
colorectal cancer
non-small cell lung cancer
pancreatic cancer
head and neck cancer
cervical cancer
tisotumab vedotin
Genmab
clinical trials
Flag link:
FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
CP Wire
Merck
Keytruda
non-small cell lung cancer
metastatic squamous non-small cell lung cancer
priority review
FDA
Flag link:
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
CP Wire
Advaxis
ADXS-NEO
immunotherapy
non-small cell lung cancer
clinical trials
Flag link:

Pages